Scholarlink

<p>Secondary metabolites derived from microorganisms have attracted considerable attention due to their diverse bioactivities relevant to the pharmaceutical industry, including antimicrobial, antioxidant, and antitumor activities. However, fungal properties remain insufficiently explored due to their extensive biodiversity. Therefore, this study aimed to characterize the metabolite profile and to evaluate the antimicrobial, antitumoral, antioxidant, antihyperglycemic, and antilipidemic activities of two fungi belonging to the genus <i>Nigrospora</i>, isolated from slaughterhouse effluent and an endophyte of <i>Myrciaria glazioviana</i>. The fungi were grown in Potato Dextrose Broth (PDB) for 15 days at 28&#xa0;°C. Ethyl acetate extracts of the fungal isolates were obtained and concentrated using a rotary evaporator. Subsequently, they were subjected to metabolomic profiling and to analyses of antimicrobial, antitumoral, and antioxidant activities using 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2’-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS⁺) assays. UHPLC putatively annotated metabolites–MS/MS analysis. Both isolates showed significant results for all tested bioactivities. Among the evaluated fungi, the <i>Nigrospora</i> sp. Mg17 isolate stood out by exhibiting bactericidal activity against <i>Staphylococcus aureus</i> ATCC 25,923 and an IC₅₀ of 479.6&#xa0;µg/mL against <i>Streptococcus agalactiae</i> ATCC 1381. Both extracts demonstrated notable antilipidemic potential, with enzymatic inhibition reaching up to 90% for <i>Nigrospora</i> sp. F4, as well as the antihyperglycemic activity of up to 51% (Mg17 extract). In the antioxidant analysis, the extract from the <i>Nigrospora</i> sp. Mg17 isolate demonstrated high efficiency, achieving 94% inhibition of the DPPH radical at 1&#xa0;mg/mL. Therefore, the results reinforce the potential of bioprospecting microorganisms from diverse environments as a promising strategy for the discovery of new bioactive fungal metabolites with pharmacological and biotechnological applications, thereby contributing to the development of more sustainable alternatives.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Biological activities and metabolic profile of crude extracts from two Nigrospora sp. isolates

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月28日

查看全文
  • Giovanna Feltrin de Freitas,
  • Thays Barbosa da Silva,
  • Ian Alejandro Fernandez Soliz,
  • Danieli Fernanda Buccini,
  • Paulo Leonardo Marotti Siciliano,
  • Natani Caroline Nogueira,
  • Paula Gimenez Milani Fernandes,
  • Julio Cesar Polonio,
  • Patricia Daniele Silva dos Santos,
  • Oscar Oliveira Santos,
  • Luiz Ricardo Olchanheski,
  • Cristiano Marcelo Espínola Carvalho,
  • Tiago Tognolli de Almeida

摘要

Secondary metabolites derived from microorganisms have attracted considerable attention due to their diverse bioactivities relevant to the pharmaceutical industry, including antimicrobial, antioxidant, and antitumor activities. However, fungal properties remain insufficiently explored due to their extensive biodiversity. Therefore, this study aimed to characterize the metabolite profile and to evaluate the antimicrobial, antitumoral, antioxidant, antihyperglycemic, and antilipidemic activities of two fungi belonging to the genus Nigrospora, isolated from slaughterhouse effluent and an endophyte of Myrciaria glazioviana. The fungi were grown in Potato Dextrose Broth (PDB) for 15 days at 28 °C. Ethyl acetate extracts of the fungal isolates were obtained and concentrated using a rotary evaporator. Subsequently, they were subjected to metabolomic profiling and to analyses of antimicrobial, antitumoral, and antioxidant activities using 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2’-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS⁺) assays. UHPLC putatively annotated metabolites–MS/MS analysis. Both isolates showed significant results for all tested bioactivities. Among the evaluated fungi, the Nigrospora sp. Mg17 isolate stood out by exhibiting bactericidal activity against Staphylococcus aureus ATCC 25,923 and an IC₅₀ of 479.6 µg/mL against Streptococcus agalactiae ATCC 1381. Both extracts demonstrated notable antilipidemic potential, with enzymatic inhibition reaching up to 90% for Nigrospora sp. F4, as well as the antihyperglycemic activity of up to 51% (Mg17 extract). In the antioxidant analysis, the extract from the Nigrospora sp. Mg17 isolate demonstrated high efficiency, achieving 94% inhibition of the DPPH radical at 1 mg/mL. Therefore, the results reinforce the potential of bioprospecting microorganisms from diverse environments as a promising strategy for the discovery of new bioactive fungal metabolites with pharmacological and biotechnological applications, thereby contributing to the development of more sustainable alternatives.